Physician
Infectious Disease
Dr. Joseph R. Dalovisio, MD
|
|
Give Review
Dr. Joseph R. Dalovisio is an expert in the field of Infectious Disease. He graduated from Tulane University School of Medicine. He over the years received 2 awards: "CMS Meaningful Use Stage 1 Certification" and "Super Doctor". Doctor Joseph R. Dalovisio, MD is a published doctor and has 32 publications published. The lastest was: 'Primary care of patients infected with human immunodeficiency virus.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Therapeutic monitoring of vancomycin in adults summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Soc...
- Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharma...
- Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of Ame...
- Dalbavancin: a novel once-weekly lipoglycopeptide antibiotic.
- Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus.
- IDSA: infancy to adulthood in four decades.
- Introduction to the west nile virus issue.
- West nile virus infection in the United States: overview as a public health issue.
- Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines.
- Financial impact of a home intravenous antibiotic program on a medicare managed care program.
- Primary care of patients infected with human immunodeficiency virus.
- Comparison of the amplified Mycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens.
- Bacteroides fragilis arthritis following cesarean section.
- Dermatologic manifestations of nontuberculous mycobacterial diseases.
- Epizootic of Mycobacterium bovis in a zoologic park.
- Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.
- Studies in homosexual patients with and without lymphadenopathy. Relationships to the acquired immune deficiency syndrome.
- Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.
- Kaposi's sarcoma with a non-Hodgkin's lymphoma. Its association in a male homosexual with human T-cell lymphotropic virus type III infection.
- Pleural effusion and anicteric hepatitis associated with cat-scratch disease. Documentation by cat-scratch bacillus.
- Listeria monocytogenes arthritis in a renal transplant recipient.
- Failure of ketoconazole treatment of Blastomyces dermatitidis [corrected] due to interaction of isoniazid and rifampin.
- Spontaneous suppressor cell activity in patients with the acquired immune deficiency syndrome and associated conditions.
- Improvement in 'stat' laboratory turnaround time. A model continuous quality improvement project.
- Rhinoceros' rhinorrhea: cause of an outbreak of infection due to airborne Mycobacterium bovis in zookeepers.
- Problems in diagnosis and therapy of Mycobacterium fortuitum infections.
- In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.
- Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.
- Myocardial sarcoidosis complicated by mural thrombosis.
- In vitro susceptibility of Nocardia asteroides to amikacin.
- Subacute thyroiditis with increased serum alkaline phosphatase.
Schools
Tulane University School Of Medicine
University Of Florida Hospital
Ochsner Clinic Foundation
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
Education
-
Ochsner Clinic Foundation -
University of Florida -
Tulane University School of Medicine
Drug Facts
| NPI NUMBER | 1548228968 | |
| NPPES Provider LastName | DALOVISIO | |
| NPPES Provider FirstName | JOSEPH | |
| NPPES Provider ZIPCode | 701212429 | |
| NPPES Provider State | LA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 2141.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 56.0 | |
| Percent Opioid Claims | 2.62 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548228968 |
| Last Name Of The Provider | DALOVISIO |
| First Name Of The Provider | JOSEPH |
| View All |
Similar Doctors
|
Dr. Yama Osmanzai, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paula S. Seal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bridget A. Ory, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shiva Akula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael E. Hagensee, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. John M. Nanfro, MD |
|
|
Dr. Richard P. Dicarlo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary J. Murphy, MD
This Doctor is OpenDoctor Recommended.
|